Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba Dropping Pills in Coronary Heart Disease With Stable Angina Pectoris and Depression
NCT04529148Phase 4Completed
- Sponsor
- Wanbangde Pharmaceutical Holding Group
- Start
- Nov 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Vasoclean in stable angina pectoris and major depressive disorder (MDD) (2 arms), sponsored by Wanbangde Pharmaceutical Holding Group. Primary endpoints: Seattle Angina Questionnaire at 12 weeks and Frequency of angina pectoris related symptoms at 12 weeks. Started Nov 2020; status: completed.
02
Drugs
Vasoclean
03
Conditions
stable angina pectorismajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04529148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04529148.